Answers are grounded in this paper and cite their sources.
Case reports reveal unusual coexistence of transthyretin and AL amyloid types in cardiac amyloidosis, indicating pathology's critical role.
Introduction/Objective Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy caused by extracellular deposition of misfolded amyloid fibrils, often leading to heart failure and arrhythmias. While its typical forms are well recognized, CA can present in atypical and diagnostically challenging ways, particularly when it coexists with other cardiac or systemic diseases. With the increasing use of advanced imaging and proteomic techniques, rare and complex presentations are being uncovered. We present two unique cases of CA—one with coexisting cardiac sarcoidosis and transthyretin amyloidosis, and another with dual amyloid subtypes (ATTR and AL) in the atrium—highlighting the diagnostic complexities. Methods/Case Report The first case involves a 59-year-old African American male with biopsy-proven pulmonary sarcoidosis affecting the lungs and lymph nodes. Subsequent cardiac evaluation revealed worsening left ventricular hypertrophy on echocardiogram, diffuse subendocardial late gadolinium enhancement on cardiac MRI and positive Tc99m-PYP scan raising the possibility of transthyretin cardiac amyloidosis. Endomyocardial biopsy confirmed the amyloidosis and also showed focal non necrotizing granulomatous inflammation consistent with a diagnosis of concomitant cardiac sarcoidosis TTR (transthyretin)-type amyloid protein was detected by Liquid chromatography-tandem mass spectrometry (LC-MS/MS) . This case is an unusual coexistence of TTR amyloidosis and sarcoidosis, with only 7 reported cases in the literature. Prior reports most commonly describe AA and AL types of CA. This case is also unusual due to the young age at presentation, given that wild -type TTR amyloidosis is most commonly diagnosed around 70 years of age. The second case is that of an 82-year-old male with a history of atrial fibrillation (Afib) and severe mitral regurgitation, for which he underwent mitral clip procedures and subsequent ablation for Afib. Two specimens were received: a mitral valve with explanted mitral clip and atrial septum. The mitral valve had fibrosis and inflammation. The atrial septum had extensive amyloid deposition, highlighted by Congo red stain and an abundant diffuse lymphohistiocytic inflammation. Well-formed granulomas were not seen. LC-MS/MS amyloid subtyping demonstrated the coexistence of dual ATTR (transthyretin)-type and AL (kappa)-type amyloid. This is an unusual combination, in contrast to the typical presentation of ANP amyloid typically found in the in the atrium. Results NA Conclusion These two cases illustrate rare and diagnostically challenging forms of cardiac amyloidosis that emphasize the critical role of pathology in diagnosis and subtyping. First case demonstrates an uncommon coexistence of ATTR wild type amyloidosis and cardiac sarcoidosis in a younger patient, expanding the known clinical spectrum. The second case highlights the presence of dual amyloid subtypes—ATTR and AL (kappa)—within the same cardiac tissue, in contrast to the typical presentation of ANP amyloid found in the atrium. This is a rarely documented phenomenon with important therapeutic implications.. Both cases underscore the value of endomyocardial biopsy and LC-MS/MS-based proteomic analysis in detecting and characterizing complex amyloid pathology.
No takes yet. Share an insight, caveat, or question.
Karimkhan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: